Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-320-5 | CAS number: 130353-58-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 08 Mar - 04 Apr 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted Jul 1997
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- The Department of Health of the Government of the United Kingdom
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Fatty acids, C16-18 and C18-hydroxy, oligomeric reaction products with adipic acid, decanoic acid, isooctadecanoic acid, octanoic acid, pentaerythritol and stearic acid
- EC Number:
- 500-320-5
- EC Name:
- Fatty acids, C16-18 and C18-hydroxy, oligomeric reaction products with adipic acid, decanoic acid, isooctadecanoic acid, octanoic acid, pentaerythritol and stearic acid
- Cas Number:
- 130353-58-1
- Molecular formula:
- not applicable, the substance is UVCB
- IUPAC Name:
- 1,6-bis({2-[(hexadecanoyloxy)methyl]-3-hydroxy-2-(hydroxymethyl)propyl}) hexanedioate; 1-{2-[(decanoyloxy)methyl]-3-hydroxy-2-[(octadecanoyloxy)methyl]propyl} 6-[3-hydroxy-2-(hydroxymethyl)-2-{[(3-methylheptadecanoyl)oxy]methyl}propyl] hexanedioate; 3-hydroxy-2-{[(6-{[3-hydroxy-2-(hydroxymethyl)-2-[(octadecanoyloxy)methyl]propyl]peroxy}-6-oxohexanoyl)oxy]methyl}-2-(hydroxymethyl)propyl 12-hydroxyoctadecanoate
Constituent 1
Method
- Target gene:
- his operon (S. typhimurium)
trp operon (E. coli)
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital and β-naphthoflavone.
- Test concentrations with justification for top dose:
- First experiment: 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate with and without metabolic activation
Second experiment: 15, 50, 150, 500, 1500 and 5000 µg/plate with and without metabolic activation - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Tetrahydrofuran
- Justification for choice of solvent/vehicle: In solubility checks performed in–house, the test item was noted as insoluble in sterile distilled water and dimethyl sulphoxide. The test item was noted as initially soluble in dimethyl formamide (50 mg/mL) and acetone (100 mg/mL), however these formulations came out of solution shortly after removal from sonication/heating and could not be considered. The test item was fully soluble in tetrahydrofuran at 200 mg/mL (this formulation stayed in solution), therefore, this solvent was selected as the vehicle.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other: 2-aminoanthracene (1, 2 and 10 µg/plate for TA100, TA1535 and TA1537, and WP2uvrA, respectively, + S9)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); preincubation
DURATION
- Preincubation period: 20 min (preincubation)
- Exposure duration: Approximately 48 h (plate incorporation and preincubation)
NUMBER OF REPLICATIONS: Triplicates each in 2 independent experiments
DETERMINATION OF CYTOTOXICITY
- Method: Reduction in the growth of the bacterial background lawn
The plates were viewed microscopically for evidence of thinning (toxicity). Manual counts were performed at 5000 μg/plate because of test item precipitation. A number of further manual counts were also performed, predominantly due to colonies spreading and bubble interference, thus distorting the actual plate count. Occasional plates were also manually assessed for accuracy (verification) against the automated counts. - Evaluation criteria:
- There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested.
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data as determined by UKEMS.
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out-of-historical range response (Cariello and Piegorsch, 1996)).
A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met.
Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit making a definite judgment about test item activity. Results of this type will be reported as equivocal. - Statistics:
- Statistical significance was confirmed by using Dunnetts Regression Analysis (* = p < 0.05) for those values that indicate statistically significant increases in the frequency of revertant colonies compared to the concurrent solvent control
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- Experiment I: starting at 1500 µg/mL; Experiment II: at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- Experiment I: starting at 1500 µg/mL; Experiment II: at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- Experiment I: starting at 1500 µg/mL; Experiment II: at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- Experiment I: starting at 1500 µg/mL; Experiment II: at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- Experiment I: starting at 1500 µg/mL; Experiment II: at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Precipitation was observed at concentrations ≥ 1500 µg/plate in Experiment I (plate incorporation) and at 5000 µg/plate in Experiment II (pre-incubation).
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: The positive control data were within the range of the historical control data.
- Negative (solvent/vehicle) historical control data: The solvent and untreated control data were within the range of the historical control data.
Any other information on results incl. tables
Table 1: Results of Experiment I (plate incorporation)
With or without S9-Mix | Test substance concentration (μg/plate) | Mean number of revertant colonies per plate | ||||
(average of 3 plates ± Standard deviation) | ||||||
Base-pair substitution type | Frameshift type | |||||
TA 100 | TA1535 | WP2uvrA | TA98 | TA1537 | ||
– | Untreated | 112 | 14 | 28 | 20 | 17 |
– | Solvent | 126 ± 13 | 15 ± 2.5 | 39 ± 12 | 22 ± 6.1 | 12 ± 3.5 |
– | 1.5 | 122 ± 19.1 | 16 ± 2.0 | 43 ± 8.4 | 37 ± 6.6 ** | 15 ± 7.8 |
– | 5 | 120 ± 10.6 | 16 ± 5.7 | 37 ± 18.5 | 32 ± 2.5 * | 17 ± 5.0 |
– | 15 | 127 ± 6.7 | 16 ± 4.5 | 42 ± 3.5 | 34 ± 3.8 ** | 16 ± 1.5 |
– | 50 | 117 ± 2.8 | 17 ± 5.0 | 40 ± 7.4 | 36 ± 4.2 ** | 19 ± 6.0 |
– | 150 | 117 ± 12.3 | 14 ± 4.7 | 31 ± 18.6 | 42 ± 2.0 *** | 22 ± 3.5 * |
– | 500 | 117 ± 14.6 | 15 ± 3.1 | 39 ± 10.7 | 33 ± 5.2 * | 24 ± 4.6 * |
– | 1500 P | 103 ± 15.6 | 13 ± 4.9 | 45 ± 3.6 | 39 ± 1.0 *** | 20 ± 3.1 |
– | 5000 P | 123 ± 13.1 | 10 ± 4.0 | 41 ± 5.5 | 31 ± 5.5 * | 16 ± 6.9 |
Positive controls, –S9 | Name | ENNG | ENNG | ENNG | 4NQO | 9AA |
Concentrations (μg/plate) | 3 | 5 | 2 | 0,2 | 80 | |
Mean No. of colonies/plate (average of 3 ± SD) | 440 ± 4.4 | 480 ± 53.5 | 844 ± 20.6 | 196 ± 15.5 | 405 ± 65.6 | |
+ | Solvent | 98 ± 6.0 | 11 ± 1.5 | 37 ± 6.4 | 34 ± 6.0 | 17 ± 2.1 |
+ | 1.5 | 111 ± 5.3 | 15 ± 1.5 | 37 ± 12.2 | 25 ± 2.3 | 17 ± 2.3 |
+ | 5 | 110 ± 4.7 | 15 ± 2.6 | 39 ± 7.5 | 26 ± 14.2 | 13 ± 3.1 |
+ | 15 | 107 ± 15.5 | 13 ± 3.8 | 40 ± 3.1 | 29 ± 4.6 | 12 ± 2.5 |
+ | 50 | 105 ± 11.7 | 18 ± 1.7 ** | 38 ± 2.1 | 29 ± 6.5 | 17 ± 1.0 |
+ | 150 | 97 ± 9.3 | 13 ± 4.0 | 34 ± 3.8 | 26 ± 3.5 | 11 ± 4.4 |
+ | 500 | 104 ± 2.6 | 11 ± 0.6 | 40 ± 2.5 | 26 ± 5.1 | 13 ± 2.6 |
+ | 1500 P | 100 ± 6.81 | 10 ± 0.0 | 32 ± 6.1 | 26 ± 4.0 | 22 ± 3.5 |
+ | 5000 P | 104 ± 2.5 | 10 ± 2.1 | 33 ± 9.8 | 23 ± 4.4 | 13 ± 1.0 |
Positive controls, +S9 | Name | 2AA | 2AA | 2AA | BP | 2AA |
Concentrations (μg/plate) | 1 | 2 | 10 | 5 | 2 | |
Mean No. of colonies/plate (average of 3 ± SD) | 700 ± 54.6 | 253 ± 16.5 | 337 ± 16.5 | 273 ± 25.1 | 278 ± 11.5 |
ENNG = N-ethyl-N-nitro-N-nitrosoguanidine
4NQO = 4-nitroquinoline-N-oxide
9AA = 9-aminoacridine
2AA = 2-Aminoanthracene
BP = Benzo(a)pyrene
P = Precipitate
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001
Table 2: Comfirmatory Experiment: Without metabolic activation (plate incorporation)
With or without S9-Mix | Test substance concentration (μg/plate) | Mean number of revertant colonies per plate | |
(average of 3 plates ± Standard deviation) | |||
Frameshift type | |||
TA98 | TA1537 | ||
– | Untreated | 18 | 16 |
– | Solvent | 32 ± 11.0 | 10 ± 3.0 |
– | 1.5 | 28 ± 4.0 | 7 ± 0.6 |
– | 5 | 33 ± 2.3 | 10 ± 3.8 |
– | 15 | 33 ± 4.7 | 12 ± 6.7 |
– | 50 | 34 ± 1.2 | 9 ± 2.1 |
– | 150 | 32 ± 2.0 | 13 ± 1.5 |
– | 500 | 33 ± 3.5 | 12 ± 6.6 |
– | 1500 P | 35 ± 3.8 | 12 ± 1.7 |
– | 5000 P | 35 ± 5.3 | 10 ± 1.0 |
Positive controls, –S9 | Name | 4NQO | 9AA |
Concentrations (μg/plate) | 0,2 | 80 | |
Mean No. of colonies/plate (average of 3 ± SD) | 209 ± 17.6 | 280 ± 30.4 |
4NQO = 4-nitroquinoline-N-oxide
9AA = 9-aminoacridine
P = Precipitate
Table 3: Results of Experiment II (pre-incubation)
With or without S9-Mix | Test substance concentration (μg/plate) | Mean number of revertant colonies per plate | ||||
(average of 3 plates ± Standard deviation) | ||||||
Base-pair substitution type | Frameshift type | |||||
TA 100 | TA1535 | WP2uvrA | TA98 | TA1537 | ||
– | Untreated | 116 | 14 | 32 | 24 | 12 |
– | Solvent | 85 ± 11.0 | 19 ± 8.1 | 34 ± 2.9 | 20 ± 3.1 | 10 ± 5.6 |
– | 15 | 93 ± 4.0 | 21 ± 1.5 | 36 ± 4.6 | 20 ± 10.4 | 8 ± 1.2 |
– | 50 | 90 ± 0.6 | 19 ± 6.2 | 24 ± 2.6 | 21 ± 0.6 | 9 ± 2.6 |
– | 150 | 86 ± 7.9 | 17 ± 4.4 | 34 ± 6.0 | 17 ± 1.5 | 10 ± 5.2 |
– | 500 | 94 ± 3.2 | 17 ± 2.6 | 35 ± 6.6 | 17 ± 8.3 | 10 ± 1.5 |
– | 1500 | 94 ± 4.7 | 12 ± 0.6 | 29 ± 3.6 | 19 ± 4.2 | 8 ± 1.5 |
– | 5000 P | 100 ± 3.0 * | 13 ± 1.5 | 36 ± 1.2 | 22 ± 3.8 | 12 ± 0.6 |
Positive controls, –S9 | Name | ENNG | ENNG | ENNG | 4NQO | 9AA |
Concentrations (μg/plate) | 3 | 5 | 2 | 0,2 | 80 | |
Mean No. of colonies/plate (average of 3 ± SD) | 773 ± 103.9 | 572 ± 26.7 | 520 ± 72.1 | 240 ± 43.8 | 160 ± 2.9 | |
+ | Solvent | 99 ± 11.7 | 10 ± 1.0 | 41 ± 4.0 | 25 ± 4.0 | 10 ± 4.0 |
+ | 15 | 107 ± 13.1 | 10 ± 2.5 | 48 ± 1.7 | 17 ± 4.0 | 8 ± 2.6 |
+ | 50 | 93 ± 1.2 | 13 ± 4.0 | 41 ± 5.1 | 24 ± 6.0 | 13 ± 5.5 |
+ | 150 | 95 ± 10.2 | 9 ± 0.6 | 35 ± 6.0 | 25 ± 7.5 | 10 ± 2.5 |
+ | 500 | 105 ± 6.5 | 8 ± 1.7 | 37 ± 15.6 | 17 ± 3.6 | 11 ± 5.0 |
+ | 1500 | 103 ± 11.1 | 15 ± 2.1 * | 43 ± 3.2 | 26 ± 1.0 | 14 ± 5.1 |
+ | 5000 P | 94 ± 11.5 | 8 ± 1.0 | 41 ± 7.5 | 24 ± 3.2 | 10 ± 2.5 |
Positive controls, +S9 | Name | 2AA | 2AA | 2AA | BP | 2AA |
Concentrations (μg/plate) | 1 | 2 | 10 | 5 | 2 | |
Mean No. of colonies/plate (average of 3 ± SD) | 980 ± 129 | 203 ± 15.6 | 234 ± 29.1 | 93 ± 22.5 | 180 ± 18.6 |
ENNG = N-ethyl-N-nitro-N-nitrosoguanidine
4NQO = 4-nitroquinoline-N-oxide
9AA = 9-aminoacridine
2AA = 2-Aminoanthracene
BP = Benzo(a)pyrene
P = Precipitate
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001
Table 4: Historical control data
Combined vehicle and untreated control values: 2015 | ||||||||||
Strain S9-Mix | TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||
-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | |
Values † | 274 | 278 | 504 | 285 | 461 | 229 | 526 | 299 | 506 | 282 |
Min | 60 | 61 | 7 | 7 | 10 | 12 | 11 | 10 | 4 | 6 |
Max | 166 | 175 | 31 | 29 | 58 | 43 | 45 | 46 | 27 | 27 |
Mean | 91 | 95 | 16 | 14 | 24 | 27 | 21 | 24 | 12 | 13 |
SD | 19.3 | 19.1 | 4.5 | 4.0 | 5.6 | 5.9 | 6.2 | 6.1 | 3.8 | 3.4 |
Positive control values 2015 | ||||||||||
Strain S9-Mix | TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||
-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | |
Values | 276 | 280 | 252 | 264 | 231 | 227 | 262 | 276 | 253 | 261 |
Min | 222 | 250 | 79 | 118 | 116 | 103 | 100 | 78 | 164 | 97 |
Max | 2266 | 2402 | 2779 | 457 | 2769 | 550 | 502 | 705 | 2318 | 823 |
Mean | 614 | 927 | 472 | 246 | 792 | 266 | 222 | 218 | 911 | 336 |
SD | 260.6 | 452.5 | 434.8 | 55.7 | 342.1 | 97.7 | 70.2 | 107.6 | 412.4 | 135.7 |
Combined vehicle and untreated control values: 2016 | ||||||||||
Strain S9-Mix | TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||
-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | |
Values | 399 | 401 | 758 | 393 | 690 | 345 | 788 | 415 | 762 | 398 |
Min | 63 | 66 | 8 | 8 | 10 | 13 | 8 | 12 | 3 | 4 |
Max | 154 | 156 | 34 | 39 | 53 | 53 | 49 | 51 | 24 | 23 |
Mean | 90 | 93 | 15 | 15 | 22 | 27 | 21 | 25 | 12 | 13 |
SD | 14.5 | 14.3 | 4.5 | 5.2 | 5.8 | 6.3 | 4.8 | 5.7 | 3.5 | 3.5 |
Positive control values 2016 | ||||||||||
Strain S9-Mix | TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||
-S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | -S9 | +S9 | |
Values | 409 | 406 | 381 | 386 | 341 | 335 | 388 | 385 | 379 | 381 |
Min | 221 | 284 | 84 | 92 | 107 | 102 | 100 | 96 | 95 | 101 |
Max | 2222 | 2863 | 2994 | 879 | 1611 | 637 | 449 | 4357 | 1413 | 639 |
Mean | 724 | 1264 | 854 | 240 | 718 | 240 | 186 | 188 | 406 | 290 |
SD | 320.4 | 562.9 | 664.9 | 62.1 | 338.6 | 98.2 | 49.8 | 230.8 | 227.0 | 92.7 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.